Platelet Indices' Usefulness in Determining whether Patients with COVID-19 Should be Treated as an Outpatient or Inpatient: a Retrospective study

dc.contributor.authorPolat, Esra
dc.contributor.authorDemir, Mehmet C.
dc.date.accessioned2021-12-01T18:48:28Z
dc.date.available2021-12-01T18:48:28Z
dc.date.issued2021
dc.department[Belirlenecek]en_US
dc.description.abstractBackground: Coronavirus disease 2019 (COVID-19) has affected the health system around the world. It is necessary to facilitate health care services with useful parameters in patient follow-up. In this study, we wanted to determine whether platelet indices can be used as an assistant parameter in the clinician's decision-making process regarding which of the patients diagnosed with COVID-19 should be treated by hospitalization. Methods: This retrospective study was performed in a secondary care hospital in Mugla, Turkey. Demographic information such as age, gender, and comorbidities of patients admitted to the emergency pandemic outpatient clinic within five months and diagnosed with COVID-19, as well as discharge, hospitalization, or intensive care needs (ICU), and thirty-day mortality were noted. Also, patients with platelet count (PLT), mean platelet volume (MPV), platelet distribution width (PDW), thrombocytocrit (PCT), MPV/PLT, MPV/PCT, PDW/PLT, PDW/PCT values for outpatient follow-up, hospitalization, intensive care unit need, and 30-day mortality relationships were examined. Results: A total of 93 patients diagnosed with COVID-19 were included in the study. It was observed that those with comorbidity had a statistically significant higher rate of hospitalization (p = 0.013). No statistically significant difference was found between outpatients and inpatients in terms of PLT, MPV, PDW, PCT, MPV/PLT, MPV/PCT, PDW/PLT, and PDW/PCT (p > 0.05 for each). Conclusions: Platelet indices such as PLT, MPV, PDW, PCT, MPV/PLT, MPV/PCT, PDW/PLT, and PDW/PCT are not useful parameters for the clinician to distinguish between outpatient and inpatient treatment of patients with COVID-19.en_US
dc.identifier.doi10.7754/Clin.Lab.2020.201144
dc.identifier.endpage1667en_US
dc.identifier.issn1433-6510
dc.identifier.issue7en_US
dc.identifier.pmid34258979en_US
dc.identifier.scopus2-s2.0-85109437564en_US
dc.identifier.scopusqualityQ3en_US
dc.identifier.startpage1662en_US
dc.identifier.urihttps://doi.org/10.7754/Clin.Lab.2020.201144
dc.identifier.urihttps://hdl.handle.net/20.500.12684/10540
dc.identifier.volume67en_US
dc.identifier.wosWOS:000684711400018en_US
dc.identifier.wosqualityQ4en_US
dc.indekslendigikaynakWeb of Scienceen_US
dc.indekslendigikaynakPubMeden_US
dc.indekslendigikaynakScopusen_US
dc.language.isoenen_US
dc.publisherClin Lab Publen_US
dc.relation.ispartofClinical Laboratoryen_US
dc.relation.publicationcategoryMakale - Uluslararası Hakemli Dergi - Kurum Öğretim Elemanıen_US
dc.rightsinfo:eu-repo/semantics/closedAccessen_US
dc.subjectCOVID-19en_US
dc.subjectemergency serviceen_US
dc.subjecthospitalizationen_US
dc.subjectmean platelet volumeen_US
dc.subjectplatelet indicesen_US
dc.subjectCounten_US
dc.titlePlatelet Indices' Usefulness in Determining whether Patients with COVID-19 Should be Treated as an Outpatient or Inpatient: a Retrospective studyen_US
dc.typeArticleen_US

Dosyalar